Previous Article | Next Article 
Journal of Virology, October 2003, p. 10780-10789, Vol. 77, No. 20
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.20.10780-10789.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
Z. Q. Xiang,1 G. P. Gao,2 A. Reyes-Sandoval,1 Y. Li,1 J. M. Wilson,2 and H. C. J. Ertl1*
The Wistar Institute,1
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania2
Received 7 May 2003/
Accepted 14 July 2003
E1 deletion adenoviral vectors of the human serotype 5 (AdHu5) and the chimpanzee serotype 68 (AdC68) expressing the rabies virus glycoprotein (rab.gp) were tested for induction of transgene product-specific antibodies upon intranasal or oral immunization of newborn mice. Both vectors induced antibodies to rabies virus that could be detected in serum and mucosal secretions. Serum rabies virus-neutralizing antibody titers sufficed to protect neonatally vaccinated mice against a subsequent challenge with rabies virus. The efficacy of the AdHu5rab.gp vector given orally to newborn mice born to AdHu5-immune dams was not impaired by maternally transferred antibodies to the vaccine carrier.
* Corresponding author. Mailing address: The Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104. Phone: (215) 898-3863. Fax: (215) 898-3953. E-mail: ertl{at}wistar.upenn.edu.
Journal of Virology, October 2003, p. 10780-10789, Vol. 77, No. 20
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.20.10780-10789.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Swenson, D. L., Wang, D., Luo, M., Warfield, K. L., Woraratanadharm, J., Holman, D. H., Dong, J. Y., Pratt, W. D.
(2008). Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections. CVI
15: 460-467
[Abstract]
[Full Text]
-
Baez-Astua, A., Herraez-Hernandez, E., Garbi, N., Pasolli, H. A., Juarez, V., zur Hausen, H., Cid-Arregui, A.
(2005). Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses. J. Virol.
79: 12807-12817
[Abstract]
[Full Text]
-
Hashimoto, M., Boyer, J. L., Hackett, N. R., Wilson, J. M., Crystal, R. G.
(2005). Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity. Infect. Immun.
73: 6885-6891
[Abstract]
[Full Text]
-
Berg, M., DiFatta, J., Hoiczyk, E., Schlegel, R., Ketner, G.
(2005). Viable adenovirus vaccine prototypes: High-level production of a papillomavirus capsid antigen from the major late transcriptional unit. Proc. Natl. Acad. Sci. USA
102: 4590-4595
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.